Bill

Bill > S1476


NJ S1476

NJ S1476
Creates "New Jersey Kratom Consumer Protection Act."


summary

Introduced
01/09/2024
In Committee
01/09/2024
Crossed Over
Passed
Dead
01/12/2026

Introduced Session

2024-2025 Regular Session

Bill Summary

This bill establishes the New Jersey Kratom Consumer Protection Act. The bill regulates the safe distribution and sale of kratom products and provides the necessary definitions for purposes of effectuating the act. The bill defines "kratom" as the tropical evergreen known as the Mitragyna speciose that is native to Southeast Asia that contains the alkaloid mitragynine, which has stimulant and opioid-like properties. The bill establishes that a kratom retailer shall disclose on the label that the product is a kratom product. The information disclosed on the label shall be regulated by the Department of Health. The Department of Health may also establish fees for registration of kratom products and may establish administrative penalties for any person who sells a kratom product with out product registration. Lastly, the bill establishes penalties and prohibitions on kratom retailers. Retailers shall not distribute or sell any kratom product to an individual under 21 years of age. If a retailer so distributes to an individual less than 21 years of age, the retailer shall be guilty of a petty disorderly offense. A petty disorderly persons offense is punishable by up to 30 days in prison, or up to a $500 penalty, or both Further, a kratom retailer shall not prepare, distribute, sell, or expose for sale: (i) any kratom product that is adulterated with a dangerous non-kratom substance; (ii) any kratom product that is contaminated with a dangerous non-kratom substance, including, but not limited to, a controlled dangerous substance as defined in the New Jersey Statutes; (iii) any kratom product containing a level of 7-hydroxymitragynine in the alkaloid fraction that is greater than 2% of the overall alkaloid composition; (iv) any kratom extract that surpasses the standards in USP-NF chapter 467; (v) any kratom product containing any synthetic alkaloids; (vi) any kratom product that does not include on its package or label the amount of mitragynine and 7-hydroxymitragynine contained in such product. Violators of these rules are subject to a $500 civil penalty for the first offense, $1,000 penalty for the second offense, and in the instance of a third offense, a retailer shall be prohibited from selling kratom products for a period of 3 years. If a retailer sells kratom products during this period, the person shall be guilty of a disorderly persons offense. A disorderly persons offense is punishable by up to 30 days in prison, a penalty up to $1,000, or both. Any retailer shall have the right to request a hearing to challenge a penalty. A retailer shall not be subject to penalty or imprisonment if it is shown by a preponderance of the evidence that the retailer relied in good faith upon the representation of the manufacturer, processor, packer, or distributor that the product represented was a kratom product.

AI Summary

This bill, titled the "New Jersey Kratom Consumer Protection Act," establishes regulations for the safe sale and distribution of kratom, a tropical evergreen plant native to Southeast Asia containing the alkaloid mitragynine, which has stimulant and opioid-like properties. The act mandates that kratom products must be clearly labeled, with the Department of Health overseeing the specific labeling requirements and potentially establishing fees for product registration and administrative penalties for unregistered products. Retailers are prohibited from selling kratom to individuals under 21 years of age, with violations resulting in a petty disorderly persons offense, punishable by up to 30 days in jail or a $500 fine. Furthermore, retailers cannot sell adulterated or contaminated kratom products, products with excessive levels of 7-hydroxymitragynine (over 2% of the alkaloid composition), extracts exceeding USP-NF chapter 467 standards, products containing synthetic alkaloids, or products lacking clear labeling of mitragynine and 7-hydroxymitragynine content. Violations of these product limitations carry escalating civil penalties of $500 for a first offense, $1,000 for a second, and a three-year ban on selling kratom for a third offense, with continued sales during the ban constituting a disorderly persons offense. Retailers can request a hearing to challenge penalties and are protected from penalties if they can prove they relied in good faith on the manufacturer's representations. The Department of Health is also tasked with adopting rules for testing, labeling, and product registration, and may conduct a study on kratom's health effects.

Committee Categories

Business and Industry

Sponsors (2)

Last Action

Introduced in the Senate, Referred to Senate Commerce Committee (on 01/09/2024)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...